HUP9901625A2 - Kondenzált pirrolszármazékok alkalmazása a TNF által befolyásolt betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, új származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények - Google Patents
Kondenzált pirrolszármazékok alkalmazása a TNF által befolyásolt betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, új származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP9901625A2 HUP9901625A2 HU9901625A HUP9901625A HUP9901625A2 HU P9901625 A2 HUP9901625 A2 HU P9901625A2 HU 9901625 A HU9901625 A HU 9901625A HU P9901625 A HUP9901625 A HU P9901625A HU P9901625 A2 HUP9901625 A2 HU P9901625A2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical compositions
- derivatives
- mediated diseases
- pyrrhoyl
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000001404 mediated effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 2
- 150000003233 pyrroles Chemical class 0.000 title 1
- -1 cyano, carboxy Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical group N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya (I) általánős képletű pirrőlszármazékők - ahől Het őlyan gyűrű, amely a pirrőlgyűrűvel kőndenzálva egy pirrőlő-tiazől-, tetrahidrő-5,6,7,8-indőlizin-, dihidrőpirrőlőtiazin- vagydihidrőpirrőlizingyűrűt képez; R1 karbamőil-, cianő-, karbőxi-, alkőxi-karbőnil-, acil- vagyimidazőlil-karbőnil-csőpőrt; R2 hidrőgén- vagy halőgénatőm, alkil-, alkenil-, trihalőgén-metil-vagy cianőcsőpőrt; R3 hidrőgén- vagy halőgénatőm, hidrőxi- vagy alkilcsőpőrt; és Het' piridil-, N-őxi-piridil- vagy tiazőlilcsőpőrt - és sóik újterápiás felhasználása a TNF által mediált betegségek kezeléséreszőlgáló gyógyszerkészítmények előállítására. Tővábbá a találmánytárgyát képezik még új, (I) általánős képletű vegyületek, azelőállításűkra szőlgáló eljárás és az ezeket tartalmazógyógyszerkészítmények . ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9507055A FR2735476B1 (fr) | 1995-06-14 | 1995-06-14 | Nouvelle application de derives du pyrrole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP9901625A2 true HUP9901625A2 (hu) | 1999-09-28 |
Family
ID=9479965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901625A HUP9901625A2 (hu) | 1995-06-14 | 1996-06-12 | Kondenzált pirrolszármazékok alkalmazása a TNF által befolyásolt betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, új származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6194426B1 (hu) |
| EP (1) | EP0833635A1 (hu) |
| JP (1) | JP2001510437A (hu) |
| KR (1) | KR19990022908A (hu) |
| AU (1) | AU6309396A (hu) |
| BR (1) | BR9609000A (hu) |
| CA (1) | CA2221027A1 (hu) |
| CZ (1) | CZ400697A3 (hu) |
| EA (1) | EA199800057A1 (hu) |
| FR (1) | FR2735476B1 (hu) |
| HU (1) | HUP9901625A2 (hu) |
| IL (1) | IL122560A0 (hu) |
| NO (1) | NO975811L (hu) |
| PL (1) | PL328669A1 (hu) |
| SK (1) | SK171697A3 (hu) |
| TR (1) | TR199701604T2 (hu) |
| TW (1) | TW336935B (hu) |
| WO (1) | WO1997000073A1 (hu) |
| ZA (1) | ZA964932B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5871537A (en) | 1996-02-13 | 1999-02-16 | Scimed Life Systems, Inc. | Endovascular apparatus |
| FR2757166B1 (fr) * | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2779724B1 (fr) * | 1998-06-10 | 2001-04-20 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US20040014744A1 (en) * | 2002-04-05 | 2004-01-22 | Fortuna Haviv | Substituted pyridines having antiangiogenic activity |
| GB0816759D0 (en) * | 2008-09-12 | 2008-10-22 | Selcia Ltd | Compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3931201A (en) * | 1974-01-22 | 1976-01-06 | The Dow Chemical Company | Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives |
| FR2539417A1 (fr) * | 1983-01-13 | 1984-07-20 | Rhone Poulenc Sante | Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent |
| FR2557111B1 (fr) | 1983-12-21 | 1986-04-11 | Rhone Poulenc Sante | Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent |
| DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
| FR2678834A1 (fr) * | 1991-07-09 | 1993-01-15 | Rhone Poulenc Rorer Sa | Nouvelle application therapeutique du pyridylpyrrolothiazole carboxamide. |
-
1995
- 1995-06-14 FR FR9507055A patent/FR2735476B1/fr not_active Expired - Fee Related
-
1996
- 1996-06-10 ZA ZA964932A patent/ZA964932B/xx unknown
- 1996-06-10 TW TW085106956A patent/TW336935B/zh active
- 1996-06-12 KR KR1019970709377A patent/KR19990022908A/ko not_active Withdrawn
- 1996-06-12 SK SK1716-97A patent/SK171697A3/sk unknown
- 1996-06-12 TR TR97/01604T patent/TR199701604T2/xx unknown
- 1996-06-12 EP EP96922100A patent/EP0833635A1/fr not_active Withdrawn
- 1996-06-12 WO PCT/FR1996/000887 patent/WO1997000073A1/fr not_active Ceased
- 1996-06-12 PL PL96328669A patent/PL328669A1/xx unknown
- 1996-06-12 CA CA002221027A patent/CA2221027A1/fr not_active Abandoned
- 1996-06-12 US US08/981,095 patent/US6194426B1/en not_active Expired - Fee Related
- 1996-06-12 AU AU63093/96A patent/AU6309396A/en not_active Abandoned
- 1996-06-12 HU HU9901625A patent/HUP9901625A2/hu unknown
- 1996-06-12 EA EA199800057A patent/EA199800057A1/ru unknown
- 1996-06-12 BR BR9609000A patent/BR9609000A/pt not_active Application Discontinuation
- 1996-06-12 JP JP50270597A patent/JP2001510437A/ja active Pending
- 1996-06-12 CZ CZ974006A patent/CZ400697A3/cs unknown
-
1997
- 1997-12-10 NO NO975811A patent/NO975811L/no not_active Application Discontinuation
- 1997-12-11 IL IL12256097A patent/IL122560A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0833635A1 (fr) | 1998-04-08 |
| TR199701604T2 (xx) | 2000-10-23 |
| CZ400697A3 (cs) | 1998-03-18 |
| ZA964932B (en) | 1997-01-06 |
| IL122560A0 (en) | 1998-06-15 |
| SK171697A3 (en) | 1998-07-08 |
| JP2001510437A (ja) | 2001-07-31 |
| AU6309396A (en) | 1997-01-15 |
| PL328669A1 (en) | 1999-02-15 |
| TW336935B (en) | 1998-07-21 |
| MX9709150A (es) | 1998-03-31 |
| EA199800057A1 (ru) | 1998-10-29 |
| WO1997000073A1 (fr) | 1997-01-03 |
| KR19990022908A (ko) | 1999-03-25 |
| FR2735476A1 (fr) | 1996-12-20 |
| BR9609000A (pt) | 1999-06-29 |
| NO975811D0 (no) | 1997-12-10 |
| CA2221027A1 (fr) | 1997-01-03 |
| NO975811L (no) | 1997-12-10 |
| US6194426B1 (en) | 2001-02-27 |
| FR2735476B1 (fr) | 1997-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002347A2 (hu) | Hidantoin-, oxazol- és pirrolszármazékok alkalmazása gyulladásos betegségek kezelésére alkalmazható gyógyszerkészítmények előállítására | |
| UA29464C2 (uk) | Активне начало лікарського засобу, призначеного для лікування хвороби паркінсона і синдромів паркінсона та спосіб одержання вказаного лікарського засобу | |
| IL160028A (en) | Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy | |
| AU2002359164A8 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
| IL127296A0 (en) | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases | |
| MY138352A (en) | Benzothiazole derivatives | |
| AP1853A (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents. | |
| HUP9802630A2 (hu) | Királis metil-fenil-oxazolidinonok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP9801599A2 (hu) | Alfa1L-agonista imidazolinszármazékok alkalmazása inkontinencia kezelésére szolgáló gyógyszerkészítmények előállítására, új imidazolin-származékok és eljárás ezek előállítására | |
| BR0009083A (pt) | Derivado de amida, processo para a preparação de um derivado de amida, composição farmacêutica, uso de um derivado de amida, método de tratamento de doenças ou de condições médicas mediadas por citocinas | |
| NL970006I2 (nl) | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. | |
| CA2258949A1 (en) | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases | |
| NO945034L (no) | Derivater i vitamin D-serien modifisert ved 20-stilling, en fremg. for frems. av slike derivater, mellomprodukter anvendt ved fremg., farmasöytiske preparater inneholdende derivatene og deres anvendelse ved frems. av legemidler | |
| MY129224A (en) | 4-phenyl-pyridine derivatives | |
| AU2002359162A1 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
| BG104983A (en) | Aryl fused azapolycyclic compounds | |
| HUP9901625A2 (hu) | Kondenzált pirrolszármazékok alkalmazása a TNF által befolyásolt betegségek kezelésére szolgáló gyógyszerkészítmények előállítására, új származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| DE69415341D1 (de) | Kondensierte tricyclische heteroaromatische derivate als liganden des dopamin-rezeptor-subtyps | |
| FI92320B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
| AU655958B2 (en) | Use of quisqualate-receptor antagonists for treating Parkinson's disease | |
| NO308852B1 (no) | Indol-2,3-dion-3-oksim-derivater, farmasøytisk blanding og anvendelse av forbindelsen | |
| HUP9701016A2 (hu) | Teofillinszármazékok alkalmazása sokkos állapotok kezelésére használható gyógyszerkészítmények előállítására, új xantinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| TNSN01001A1 (fr) | NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION | |
| FI911533A7 (fi) | Bentsoksatsiini-johdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö sairauksien hoitamiseen tai ennalta ehkäisemiseksi | |
| HUP0203161A2 (hu) | Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |